The target: bacterial protease ClpP - Image: M. Gersch / TUM
The target: bacterial protease ClpP - Image: M. Gersch / TUM

New mechanisms of action open alternative approaches to antibiotics development:Two new weapons in the battle against bacteria

Proteases are vital proteins that serve for order within cells. They break apart other proteins, ensuring that these are properly synthesized and decomposed. Proteases are also responsible for the pathogenic effects of many kinds of bacteria. Now chemists at the Technische Universität München (TUM) have discovered two hitherto unknown mechanisms of action that can be used to permanently disarm an important bacterial protease.

Proteins are made up of a chain of amino acids and are vital for all cell processes. Proteases are among the most important types of protein. Like “molecular scissors”, they cut other proteins at given positions and thereby execute important cell functions. By cutting the amino acid chains to the right length or breaking proteins apart they, for example, activate or deactivate proteins, decompose defective ones or switch signal sequences that serve to transport proteins to their proper position within a cell.

But proteases are important not only for human cells – bacteria also rely on them. There are hardly any effective antibiotics left in the fight against pathogens like multi-resistant strains of Staphylococcus aureus bacteria or Mycobacterium tuberculosis which causes tuberculosis.

Researchers around the world are thus working ardently to find new ways of disarming the proteases in these strains to combat them. At the heart of this effort lies the so-called ClpP protease. It comprises 14 subunits and has a central regulatory function. The usual approach to deactivating this protease is to block all active centers of the ClpP. These are effectively the “cutting edges of the scissors”, i.e. the portions of the protein that are responsible for breaking apart other proteins.

“However, the inhibitors used in the past have one decisive disadvantage,” explains Stephan Sieber who heads the Chair for Organic Chemistry II at the Technische Universität München (TUM). “They don’t permanently disarm the proteins, but only work for a few hours. On top of that, to be effective they must attack all active centers of the protein.”

New strategies against bacteria

In collaboration with Professor Michael Groll, who heads the Chair for Biochemistry, Malte Gersch and Roman Kolb, doctoral candidates at Professor Sieber’s chair, have succeeded in uncovering two completely new mechanisms that can be used to permanently deactivate these important bacteriological proteases – in one case even without having to attack all active centers of the protein.

The first mechanism disrupts the arrangement of amino acids required for the cohesion of the protease subunits. As a result the protease breaks into two parts. The second acts directly on the core of the active center. It converts the amino acid that does the actual splitting into another kind of amino acid – the “scissors” lose their edge and the protein is rendered inoperable. Both approaches inhibit the protease in completely novel ways and are thus very promising for the development of new forms of medication.

The scientists also found a whole series of inhibitors that initiate the two mechanisms. “Knowing the ways in which substances deactivate the proteases is a huge advance,” says Gersch. “We can now optimize the substances and possibly also apply the principle to other proteases.”

In further research, Gersch and Sieber plan to test their substances on living bacterial strains to determine if these are truly inhibited in growth and pathogenic effect. “Although the bacteria are not completely disarmed, they produce significantly fewer toxins that are conducive to inflammation,” says Gersch. “The basic idea is that we give the immune system more time to handle the pathogens on its own while the formation of new resistances is suppressed.”

The research was funded by the Deutsche Forschungsgemeinschaft (DFG; SFB 749 and SFB 1035, Cluster of Excellence Center for Integrated Protein Research Munich (CIPSM)), by the European Research Council (ERC starting grant), the Fund of the German Chemical Industry and the German National Academic Foundation. The crystal structures were determined in collaboration with the synchrotron radiation source of the Paul Scherrer Institute in Villigen (Switzerland).

Publication:

Malte Gersch, Roman Kolb, Ferdinand Alte, Michael Groll, Stephan Sieber. Disruption of Oligomerization and Dehydroalanine Formation as Mechanisms for ClpP Protease Inhibition. Journal of the American Chemical Society (JACS), 2014, 136 (4), pp 1360-1366 –DOI: 10.1021/ja4082793

Contact:

Prof. Stephan A. Sieber
Chair for Organic Chemistry II
Technische Universität München
Lichtenbergstr. 4, 85747 Garching, Germany
Tel.: +49 89 289 13302 / 13301 (Sekr.)
E-Mail – Web

Technical University of Munich


Article at tum.de

Prof. Dr. Stephan A. Sieber

Stephan A. Sieber receives Future Insight Prize

Stephan A. Sieber, Professor for Organic Chemistry at the Technical University of Munich (TUM) has been awarded the 2020 Future Insight Prize for his research on the development of new strategies against multidrug-resistant...

PhD-student Robert Macsics examining an agar plate on which colonies of the Staphylococcus aureus bacteria have grown. The color change of the plate from red to yellow in the area of the bacterial colonies indicates that they are bacteria of the species S. aureus.

From cancer medication to antibiotic

Antibiotic-resistant bacteria are increasingly the source of deadly infections. A team of scientists from the Technical University of Munich (TUM) and the Helmholtz Center for Infection Research (HZI) in Braunschweig have...

Three cryo-electron microscopic views of the protein complex ClpX-ClpP.

Weak spot in pathogenic bacteria

Antibiotics are still the most important weapon for combatting bacterial infections. But medical science is running out of “ammunition” because of more and more frequently occurring resistances. A research team has now...

Prof. Stephan A. Sieber und Dr. Sabine Schneider im Labor des Lehrstuhls für Organische Chemie II der TU München. (Bild: A. Battenberg / TUM)

New targets in the battle against antibiotic resistance

More and more bacteria are resistant to available antibiotics. A team of chemists from the Technical University of Munich (TUM) now presents a new approach: they have identified important enzymes in the metabolism of...

Staphylococcus aureus Bakterienkultur auf einer Agarplatte. (Bild: ksass / istockphoto)

Bacterial toxins override key immune system check

Staphylococcus aureus bacteria can cause numerous diseases, such as skin infections, pneumonia and blood poisoning (sepsis). The strong immune response triggered by the bacteria is an aggravating factor here. One reason for...

Dr. Johannes Lehmann (links) und Prof. Sephan A. Sieber begutachten Testergebnisse zur antibakteriellen Wirkung verschiedener Substanzen. (Foto: Christian Fetzer / TUM)

Double strike against tuberculosis

In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally....

Aufnahmen von Harnsäurekristallen: Harnsäure bildet nadelförmige Kristalle, die das Immunsystem aktivieren. (Bild: K. Neumann/TUM)

A braking system for immune responses

For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control immune...